Literature DB >> 21622714

Caveolin-1 upregulation mediates suppression of primary breast tumor growth and brain metastases by stat3 inhibition.

Wen-Tai Chiu1, Hsueh-Te Lee, Feng-Ju Huang, Kenneth D Aldape, Jun Yao, Patricia S Steeg, Cheng-Yang Chou, Zhimin Lu, Keping Xie, Suyun Huang.   

Abstract

Stat3 activation has been implicated as an important driver of brain metastasis in breast cancer, but the critical targets of Stat3 in this process are yet to be fully defined. In this study, we identified the lipid raft organizing protein Caveolin-1 (Cav-1) as a critical genetic target of Stat3 in this process. In human breast cancers, we found that activated Stat3 correlated with attenuation of Cav-1 in brain metastases relative to primary tumors. Cav-1 promoter activity and gene expression were increased by overexpressing an activated form of Stat3 but decreased by attenuation of Stat3 activity or expression. We identified putative Stat3-binding elements in the Cav-1 promoter and showed a direct repression of Cav-1 transcription by Stat3. Reciprocally, we showed that strategies to increase or decrease Cav-1 expression were sufficient to attenuate or promote breast cancer cell invasion. Furthermore, increased expression of Cav-1 phenocopied the effects of Stat3 activation in blocking primary tumor growth and abrogating formation of brain metastases. Collectively, our findings provide clinical and mechanistic evidence that Cav-1 is a critical target for suppression by Stat3 in driving invasion and metastasis of breast cancer cells. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21622714      PMCID: PMC4170798          DOI: 10.1158/0008-5472.CAN-10-4249

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

1.  Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice.

Authors:  M Drab; P Verkade; M Elger; M Kasper; M Lohn; B Lauterbach; J Menne; C Lindschau; F Mende; F C Luft; A Schedl; H Haller; T V Kurzchalia
Journal:  Science       Date:  2001-08-09       Impact factor: 47.728

Review 2.  Stat proteins and oncogenesis.

Authors:  Jacqueline Bromberg
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

3.  p42/44 MAP kinase-dependent and -independent signaling pathways regulate caveolin-1 gene expression. Activation of Ras-MAP kinase and protein kinase a signaling cascades transcriptionally down-regulates caveolin-1 promoter activity.

Authors:  J A Engelman; X L Zhang; B Razani; R G Pestell; M P Lisanti
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

4.  Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells.

Authors:  Giusy Fiucci; Dana Ravid; Reuven Reich; Mordechai Liscovitch
Journal:  Oncogene       Date:  2002-04-04       Impact factor: 9.867

5.  Invasion activating caveolin-1 mutation in human scirrhous breast cancers.

Authors:  K Hayashi; S Matsuda; K Machida; T Yamamoto; Y Fukuda; Y Nimura; T Hayakawa; M Hamaguchi
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

6.  Molecular basis for the critical role of suppressor of cytokine signaling-1 in melanoma brain metastasis.

Authors:  Feng-Ju Huang; Patricia S Steeg; Janet E Price; Wen-Tai Chiu; Ping-Chieh Chou; Keping Xie; Raymond Sawaya; Suyun Huang
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

7.  Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain.

Authors:  Diane Palmieri; Julie L Bronder; Jeanne M Herring; Toshiyuki Yoneda; Robert J Weil; Andreas M Stark; Raffael Kurek; Eleazar Vega-Valle; Lionel Feigenbaum; Douglas Halverson; Alexander O Vortmeyer; Seth M Steinberg; Kenneth Aldape; Patricia S Steeg
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

8.  Suppressor of cytokine signaling (SOCS)-1 is expressed in human prostate cancer and exerts growth-inhibitory function through down-regulation of cyclins and cyclin-dependent kinases.

Authors:  Hannes Neuwirt; Martin Puhr; Frédéric R Santer; Martin Susani; Wolfgang Doppler; Gemma Marcias; Veronika Rauch; Maria Brugger; Alfred Hobisch; Lukas Kenner; Zoran Culig
Journal:  Am J Pathol       Date:  2009-03-26       Impact factor: 4.307

9.  Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice.

Authors:  Maciej Kujawski; Marcin Kortylewski; Heehyoung Lee; Andreas Herrmann; Heidi Kay; Hua Yu
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

10.  Caveolin-1 regulating the invasion and expression of matrix metalloproteinase (MMPs) in pancreatic carcinoma cells.

Authors:  Fei Han; Hong-Guang Zhu
Journal:  J Surg Res       Date:  2009-05-03       Impact factor: 2.192

View more
  35 in total

1.  βIII-Tubulin Regulates Breast Cancer Metastases to the Brain.

Authors:  Deepak Kanojia; Ramin A Morshed; Lingjiao Zhang; Jason M Miska; Jian Qiao; Julius W Kim; Peter Pytel; Irina V Balyasnikova; Maciej S Lesniak; Atique U Ahmed
Journal:  Mol Cancer Ther       Date:  2015-02-27       Impact factor: 6.261

2.  Deletion of caveolin scaffolding domain alters cancer cell migration.

Authors:  Sunaho Okada; Sadaf A Raja; Jonathan Okerblom; Aayush Boddu; Yousuke Horikawa; Supriyo Ray; Hideshi Okada; Itta Kawamura; Yoshiteru Murofushi; Fiona Murray; Hemal H Patel
Journal:  Cell Cycle       Date:  2019-05-22       Impact factor: 4.534

3.  JAK2-binding long noncoding RNA promotes breast cancer brain metastasis.

Authors:  Shouyu Wang; Ke Liang; Qingsong Hu; Ping Li; Jian Song; Yuedong Yang; Jun Yao; Lingegowda Selanere Mangala; Chunlai Li; Wenhao Yang; Peter K Park; David H Hawke; Jianwei Zhou; Yan Zhou; Weiya Xia; Mien-Chie Hung; Jeffrey R Marks; Gary E Gallick; Gabriel Lopez-Berestein; Elsa R Flores; Anil K Sood; Suyun Huang; Dihua Yu; Liuqing Yang; Chunru Lin
Journal:  J Clin Invest       Date:  2017-11-13       Impact factor: 14.808

4.  A novel FoxM1-caveolin signaling pathway promotes pancreatic cancer invasion and metastasis.

Authors:  Chen Huang; Zhengjun Qiu; Liwei Wang; Zhihai Peng; Zhiliang Jia; Craig D Logsdon; Xiangdong Le; Daoyan Wei; Suyun Huang; Keping Xie
Journal:  Cancer Res       Date:  2011-12-22       Impact factor: 12.701

Review 5.  Breast cancer brain metastasis: molecular mechanisms and directions for treatment.

Authors:  Rute M S M Pedrosa; Dana A Mustafa; Riccardo Soffietti; Johan M Kros
Journal:  Neuro Oncol       Date:  2018-10-09       Impact factor: 12.300

6.  Effect of caveolin-1 on Stat3-ptyr705 levels in breast and lung carcinoma cells.

Authors:  Mulu Geletu; Zaid Taha; Rozanne Arulanandam; Reva Mohan; Hikmat H Assi; Maria G Castro; Ivan Robert Nabi; Patrick T Gunning; Leda Raptis
Journal:  Biochem Cell Biol       Date:  2019-04-15       Impact factor: 3.626

7.  ∆Np73beta induces caveolin-1 in human non-small cell lung cancer cell line H1299.

Authors:  Elisa Caiola; Eleonora Marrazzo; Simona Alesci; Massimo Broggini; Mirko Marabese
Journal:  Tumour Biol       Date:  2015-09-04

8.  Genes related to suppression of malignant phenotype induced by Maitake D-Fraction in breast cancer cells.

Authors:  Eliana Noelia Alonso; Manuela Orozco; Alvaro Eloy Nieto; Gabriela Andrea Balogh
Journal:  J Med Food       Date:  2013-07       Impact factor: 2.786

9.  miR-21, miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer.

Authors:  J Zhang; Z Xiao; D Lai; J Sun; C He; Z Chu; H Ye; S Chen; J Wang
Journal:  Br J Cancer       Date:  2012-06-07       Impact factor: 7.640

10.  Innovative therapeutic strategies in the treatment of brain metastases.

Authors:  Maria Caffo; Valeria Barresi; Gerardo Caruso; Mariano Cutugno; Giuseppe La Fata; Mario Venza; Concetta Alafaci; Francesco Tomasello
Journal:  Int J Mol Sci       Date:  2013-01-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.